Brain morphology and information processing at the completion of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia

被引:6
作者
Darling, Simone [1 ,2 ]
De Luca, Cinzia Rachele [1 ,3 ]
Anderson, Vicki [1 ,2 ,4 ]
McCarthy, Maria [1 ,3 ]
Hearps, Stephen [1 ]
Seal, Marc [1 ,2 ]
机构
[1] Murdoch Childrens Res Inst, Clin Sci, Parkville, Vic, Australia
[2] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia
[3] Royal Childrens Hosp, Childrens Canc Ctr, Melbourne, Vic, Australia
[4] Royal Childrens Hosp, Psychol Dept, Melbourne, Vic, Australia
关键词
Acute lymphoblastic leukemia; cognition; information processing; morphometry; pediatric; LONG-TERM SURVIVORS; WHITE-MATTER CHANGES; NEUROCOGNITIVE OUTCOMES; CHILDHOOD-CANCER; CORTICAL THICKNESS; INDUCED NEUROTOXICITY; ADULT SURVIVORS; SURFACE-AREA; FOLLOW-UP; CHILDREN;
D O I
10.1080/17518423.2018.1492988
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Approximately 50% of survivors of childhood acute lymphoblastic leukemia (ALL) demonstrate cognitive impairments. However, the trajectory of change and contributing neuropathology is unclear, limiting our ability to tailor intervention content and timing. This study aimed to explore information processing abilities and brain morphology early post-treatment for pediatric ALL. Procedure: Twenty-one children at the end of ALL treatment and 18 controls underwent neuropsychological assessment. A subset also completed structural magnetic resonance imaging. Results: A principal component analysis generated two cognitive factors: information processing capacity and information processing speed. Compared to control group, the ALL group displayed deficits in capacity, but not speed. No group differences were identified in morphology. No relationship was identified between capacity or speed and morphology. Conclusion: Early cognitive intervention should target information processing abilities using a system-wide approach. Future studies should employ alternative imaging techniques sensitive to white-matter microstructure when exploring pathology underlying information processing deficits.
引用
收藏
页码:293 / 302
页数:10
相关论文
共 50 条
  • [31] An Overview of Conventional Drugs and Nanotherapeutic Options for the Treatment and Management of Pediatric Acute Lymphoblastic Leukemia
    Yohan, Andre
    Jacques, Christopher
    Fletcher, Tafaswa
    Suk-In, Thanaphorn
    Campbell, Robert B.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022, 22 (18) : 3050 - 3061
  • [32] Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy
    Uckun, FM
    Nachman, JB
    Sather, HN
    Sensel, MG
    Kraft, P
    Steinherz, PG
    Lange, B
    Hutchinson, R
    Reaman, GH
    Gaynon, PS
    Heerema, NA
    LEUKEMIA & LYMPHOMA, 1999, 33 (1-2) : 101 - 106
  • [33] Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
    Place, Andrew E.
    Karol, Seth E.
    Forlenza, Christopher J.
    Cooper, Todd M.
    Fraser, Christopher
    Cario, Gunnar
    O'Brien, Maureen M.
    Gerber, Nicolas U.
    Bourquin, Jean-Pierre
    Reinhardt, Dirk
    Rubnitz, Jeffrey E.
    Opferman, Joseph T.
    Sunkersett, Gauri
    Onishi, Maika
    Dunshee, Diana R.
    Chen, Xin
    Unnebrink, Kristina
    Vishwamitra, Deeksha
    Dunbar, Fengjiao
    Badawi, Mohamed
    Ross, Jeremy A.
    Loh, Mignon L.
    PEDIATRIC BLOOD & CANCER, 2025,
  • [34] Cytomegalovirus Retinitis Diagnosed After Completion of Chemotherapy for Acute Lymphoblastic Leukemia in an Adolescent
    Han, Seung Beom
    Lee, Jin Hee
    Lee, Jae Wook
    Chung, Nack-Gyun
    Cho, Bin
    Kang, Jin Han
    Kim, Hack-Ki
    Lee, Jin Hae
    Lee, Won Ki
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2015, 37 (02) : E128 - E130
  • [35] Cost-Effectiveness of Treatment of Childhood Acute Lymphoblastic Leukemia With Chemotherapy Only: The Influence of New Medication and Diagnostic Technology
    van Litsenburg, Raphaele R. L.
    Uyl-de Groot, Carin A.
    Raat, Hein
    Kaspers, Gertjan J. L.
    Gemke, Reinoud J. B. J.
    PEDIATRIC BLOOD & CANCER, 2011, 57 (06) : 1005 - 1010
  • [36] A cost analysis of individualized asparaginase treatment in pediatric acute lymphoblastic leukemia
    Kloos, Robin Q. H.
    Uyl-de Groot, Carin A.
    van Litsenburg, Raphaele R. L.
    Kaspers, Gertjan J. L.
    Pieters, Rob
    van der Sluis, Inge M.
    PEDIATRIC BLOOD & CANCER, 2017, 64 (12)
  • [37] Treatment of Pediatric Acute Lymphoblastic Leukemia: A Historical Perspective
    Hayashi, Hiroshi
    Makimoto, Atsushi
    Yuza, Yuki
    CANCERS, 2024, 16 (04)
  • [38] Incidence and risk factors for hypoglycemia during maintenance chemotherapy in pediatric acute lymphoblastic leukemia
    Rosenfeld, Elizabeth
    Getz, Kelly D.
    Miller, Tamara P.
    Seif, Alix E.
    Fisher, Brian T.
    Burrows, Evanette
    Ramos, Mark Jason
    De Leon, Diva D.
    Aplenc, Richard
    Morales, Knashawn H.
    Guevara, James P.
    PEDIATRIC BLOOD & CANCER, 2022, 69 (06)
  • [39] Structural brain alteration in survivors of acute lymphoblastic leukemia with chemotherapy treatment: A voxel-based morphometry and diffusion tensor imaging study
    Zou, Liwei
    Su, Lianzi
    Xu, Jiajia
    Xiang, Li
    Wang, Longsheng
    Zhai, Zhimin
    Zheng, Suisheng
    BRAIN RESEARCH, 2017, 1658 : 68 - 72
  • [40] Body mass trajectory from diagnosis to the end of treatment in a pediatric acute lymphoblastic leukemia cohort
    Galati, Paula Cristina
    Rocha, Priscilla Roberta Silva
    Gruezo, Nadia Dias
    Amato, Angelica Amorim
    SCIENTIFIC REPORTS, 2023, 13 (01)